FI60567C - Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning - Google Patents

Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning Download PDF

Info

Publication number
FI60567C
FI60567C FI2099/73A FI209973A FI60567C FI 60567 C FI60567 C FI 60567C FI 2099/73 A FI2099/73 A FI 2099/73A FI 209973 A FI209973 A FI 209973A FI 60567 C FI60567 C FI 60567C
Authority
FI
Finland
Prior art keywords
gel
capa
fraction
process according
cancer
Prior art date
Application number
FI2099/73A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI60567B (fi
Inventor
Knut Bertil Bjoerklund
Original Assignee
Bonnierfoeretagen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonnierfoeretagen Ab filed Critical Bonnierfoeretagen Ab
Application granted granted Critical
Publication of FI60567B publication Critical patent/FI60567B/fi
Publication of FI60567C publication Critical patent/FI60567C/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI2099/73A 1972-07-10 1973-06-29 Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning FI60567C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27027372A 1972-07-10 1972-07-10
US27027372 1972-07-10

Publications (2)

Publication Number Publication Date
FI60567B FI60567B (fi) 1981-10-30
FI60567C true FI60567C (fi) 1982-02-10

Family

ID=23030635

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2099/73A FI60567C (fi) 1972-07-10 1973-06-29 Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning

Country Status (22)

Country Link
JP (2) JPS5817168B2 (no)
AR (1) AR197243A1 (no)
AT (1) AT336780B (no)
BE (1) BE802126A (no)
BR (1) BR7305142D0 (no)
CA (1) CA1039650A (no)
CH (1) CH617853A5 (no)
DD (2) DD118946A5 (no)
DE (2) DE2333740C2 (no)
DK (1) DK139898B (no)
ES (1) ES416726A1 (no)
FI (1) FI60567C (no)
FR (1) FR2191885B1 (no)
GB (2) GB1443053A (no)
IL (1) IL42594A (no)
IN (1) IN138903B (no)
IT (1) IT1009527B (no)
NL (1) NL7309257A (no)
NO (1) NO146338C (no)
SE (3) SE440697B (no)
SU (1) SU581842A3 (no)
ZA (1) ZA734632B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS56145297A (en) * 1980-04-11 1981-11-11 Kureha Chem Ind Co Ltd Preparative method of glycoprotein having immunosupressing activity
EP0087898A1 (en) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Antibodies and antigens useful in the diagnosis and treatment of cancer

Also Published As

Publication number Publication date
BE802126A (fr) 1973-11-05
DE2333740A1 (de) 1974-01-31
ZA734632B (en) 1974-06-26
CH617853A5 (en) 1980-06-30
NL7309257A (no) 1974-01-14
GB1443054A (en) 1976-07-21
IN138903B (no) 1976-04-10
ES416726A1 (es) 1976-06-16
FR2191885A1 (no) 1974-02-08
IL42594A (en) 1976-08-31
DD113918A5 (no) 1975-07-05
JPS56115954A (en) 1981-09-11
DE2366609C2 (no) 1988-02-25
SE440597B (sv) 1985-08-12
JPS5817168B2 (ja) 1983-04-05
DD118946A5 (no) 1976-03-20
FR2191885B1 (no) 1977-07-01
AU5728673A (en) 1975-01-09
BR7305142D0 (pt) 1974-08-22
JPS6018011B2 (ja) 1985-05-08
SE418186B (sv) 1981-05-11
SU581842A3 (ru) 1977-11-25
SE7609836L (sv) 1976-09-06
IL42594A0 (en) 1973-08-29
IT1009527B (it) 1976-12-20
DE2333740C2 (de) 1987-01-22
GB1443053A (en) 1976-07-21
NO146338C (no) 1982-09-08
DK139898B (da) 1979-05-14
JPS4955823A (no) 1974-05-30
SE7609837L (sv) 1976-09-06
AT336780B (de) 1977-05-25
FI60567B (fi) 1981-10-30
NO146338B (no) 1982-06-01
AR197243A1 (es) 1974-03-22
SE440697B (sv) 1985-08-12
CA1039650A (en) 1978-10-03
ATA600773A (de) 1976-09-15
DK139898C (no) 1979-10-08

Similar Documents

Publication Publication Date Title
US4160018A (en) Stabilized cancer associated polypeptide antigen and preparation thereof
US3960827A (en) Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US5310653A (en) Tumor marker protein and antibodies thereto for cancer risk assessment or diagnosis
Kupchik et al. Carcinoembryonic antigen (s) in liver disease: II. Isolation from human cirrhotic liver and serum and from normal liver
Bhattacharya et al. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor‐associated antigens
US4298590A (en) Detection of malignant tumor cells
Goldenberg et al. Antigens associated with normal and malignant gastrointestinal tissues
US5866690A (en) Detection of malignant tumor cells
JPS6129464B2 (no)
Imamura et al. Analysis of human ovarian tumor antigens using heterologous antisera: detection of new antigenic systems
US4486538A (en) Detection of malignant tumor cells
Solomon Molecular heterogeneity of immunoglobulin-M (γM-globulin)
Alpert Alpha-I-Fetoprotein: Serologic Marker of Hu-man Hepatoma and Embryonal Carcinoma¹2
US4211766A (en) Cancer associated polypeptide antigen compositions
FI60567C (fi) Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning
Halliday et al. Isoferritin composition of tissues and serum in human cancers
Neville et al. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma.
JPS6259783B2 (no)
Harvey et al. Demonstration of two molecular variants of carcinoembryonic antigen by concanavalin A sepharose affinity chromatography
Hamashige et al. Immunologic and biologic study of human chorionic gonadotropin
BJÖRKLUND et al. IMMUNO‐HISTOCHEMICAL LOCALIZATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) AND CARCINO‐EMBRYONIC ANTIGEN (CEA) IN BREAST CANCER: A Comparative Study
Dickinson et al. The chemical nature of cancer basic protein
Hirai Carcinofetal proteins
CN102336828A (zh) 一种多发性骨髓瘤特异性蛋白及其专用检测试剂盒
McPherson et al. Carcinoembryonic antigen (CEA): Comparison of the farr and solid‐phase methods for detection of CEA